% alzhub.org library filter
% Source: https://alzhub.org/research?author=Ernstrom+K&access=free
% 6 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{grill2020-32777010,
  author  = {Grill, J. D. and Raman, R. and Ernstrom, K. and Sultzer, D. L. and Burns, J. M. and Donohue, M. C. and Johnson, K. A. and Aisen, P. S. and others},
  title   = {{Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2020.2734},
  pmid    = {32777010},
  url     = {https://doi.org/10.1001/jamaneurol.2020.2734}
}

@article{sperling2021-33464300,
  author  = {Sperling, R. and Henley, D. and Aisen, P. S. and Raman, R. and Donohue, M. C. and Ernstrom, K. and Rafii, M. S. and Streffer, J. and others},
  title   = {{Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2020.4857},
  pmid    = {33464300},
  url     = {https://doi.org/10.1001/jamaneurol.2020.4857}
}

@article{grill2024-37830926,
  author  = {Grill, J. D. and Flournoy, C. and Dhadda, S. and Ernstrom, K. and Sperling, R. and Molina-Henry, D. and Tranotti, K. and Harris, R. and others},
  title   = {{Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease}},
  journal = {Annals of neurology},
  year    = {2024},
  doi     = {10.1002/ana.26819},
  pmid    = {37830926},
  url     = {https://doi.org/10.1002/ana.26819}
}

@article{grill2024-38585443,
  author  = {Grill, J. D. and Raman, R. and Ernstrom, K. and Wang, S. and Donohue, M. C. and Aisen, P. S. and Karlawish, J. and Henley, D. and others},
  title   = {{Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial}},
  journal = {Neurology. Clinical practice},
  year    = {2024},
  doi     = {10.1212/cpj.0000000000200265},
  pmid    = {38585443},
  url     = {https://doi.org/10.1212/cpj.0000000000200265}
}

@article{grill2013-23255824,
  author  = {Grill, J. D. and Raman, R. and Ernstrom, K. and Aisen, P. and Karlawish, J.},
  title   = {{Effect of study partner on the conduct of Alzheimer disease clinical trials}},
  journal = {Neurology},
  year    = {2013},
  doi     = {10.1212/wnl.0b013e31827debfe},
  pmid    = {23255824},
  url     = {https://doi.org/10.1212/wnl.0b013e31827debfe}
}

@article{raman2009-19571733,
  author  = {Raman, R. and Thomas, R. G. and Weiner, M. W. and Jack, C. R. and Ernstrom, K. and Aisen, P. S. and Tariot, P. N. and Quinn, J. F.},
  title   = {{MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2009},
  doi     = {10.1097/wad.0b013e3181aba588},
  pmid    = {19571733},
  url     = {https://doi.org/10.1097/wad.0b013e3181aba588}
}